RELATED SERVICE:
Industrial & Manufacturing Markets
Actionable Benefits
- Understand the reasons why companies operating in the pharmaceutical value chain need to upgrade their software.
- Identify suppliers that are looking to support firms’ drug discovery, clinical trials, and manufacturing activities.
- Evaluate suppliers’ approaches to serving customer needs.
Research Highlights
- Concise backdrop to how software supports pharmaceutical firms’ efforts to bring drugs to market sooner, while remaining regulatory compliant.
- Profiles of 12 vendors looking to improve the lives of practitioners in laboratories, those running clinical trials, and those tasked with producing the drugs, medicines, and vaccines.
- An “ABI Research Verdict” on each vendor’s solution.
Critical Questions Answered
- What are the key focus areas for software suppliers when engaging with different parts of the pharmaceutical value chain?
- What drives and inhibits investments in software solutions.
- The main tenants of vendors’ solutions and ABI Research’s thoughts on how well they meet market requirements.
Who Should Read This?
- Decision makers responsible for optimizing processes at pharmaceutical firms and their partners.
- System integrators who need to understand the potential role for software solutions at their client sites.
- Vendor marketing leads looking to understand how competitors are positioning their capabilities.
- Decision makers and strategists within: Device Original Equipment Manufacturers (OEMs) Software platform vendors Investment banks
- Device Original Equipment Manufacturers (OEMs) Software platform vendors Investment banks
- Device Original Equipment Manufacturers (OEMs)
- Software platform vendors
- Investment banks